Use of GELSECTAN

GELSECTAN® irritable bowel syndrome tannins xylo-oligosaccharides xyloglucan

Journal

Patient preference and adherence
ISSN: 1177-889X
Titre abrégé: Patient Prefer Adherence
Pays: New Zealand
ID NLM: 101475748

Informations de publication

Date de publication:
2021
Historique:
received: 12 05 2021
accepted: 04 08 2021
entrez: 20 8 2021
pubmed: 21 8 2021
medline: 21 8 2021
Statut: epublish

Résumé

Irritable bowel syndrome is a chronic functional gastrointestinal disorder characterized by recurrent chronic abdominal pain and impaired bowel habits, which affects daily activity and work productivity, and is associated with a significant healthcare economic burden as well as an impaired quality of life and psycho-affective profile. Management of patients is a great challenge for physicians; at the present, the therapeutic strategy aimed to treat the different symptoms, and no medical therapy is proven to modify the natural history of the disease. GELSECTAN

Identifiants

pubmed: 34413634
doi: 10.2147/PPA.S318859
pii: 318859
pmc: PMC8370582
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1763-1774

Informations de copyright

© 2021 Bellini et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

N Engl J Med. 2012 Oct 25;367(17):1626-35
pubmed: 23094724
Nutrients. 2020 Dec 10;12(12):
pubmed: 33321805
Neurogastroenterol Motil. 2014 Mar;26(3):296-302
pubmed: 24548256
Lancet. 2020 Nov 21;396(10263):1675-1688
pubmed: 33049223
Gut. 2006 Oct;55(10):1512-20
pubmed: 16966705
J Gastroenterol. 2016 Aug;51(8):768-78
pubmed: 27048502
Aliment Pharmacol Ther. 2016 Oct;44(7):693-703
pubmed: 27492648
Int J Biol Macromol. 2017 Nov;104(Pt A):799-812
pubmed: 28648637
Gut. 2016 Dec;65(12):1951-1959
pubmed: 26347530
Gut. 2015 Sep;64(9):1379-88
pubmed: 25209656
Gut. 2009 Feb;58(2):196-201
pubmed: 18824556
Expert Rev Gastroenterol Hepatol. 2021 Mar;15(3):325-331
pubmed: 33028102
Expert Rev Gastroenterol Hepatol. 2018 Jan;12(1):83-90
pubmed: 28946778
Gastroenterology. 2021 Jan;160(1):99-114.e3
pubmed: 32294476
Nutrients. 2017 Dec 15;9(12):
pubmed: 29244718
Health Qual Life Outcomes. 2013 Dec 13;11:208
pubmed: 24330412
Tech Coloproctol. 2018 Aug;22(8):569-571
pubmed: 30083779
Mol Nutr Food Res. 2009 Sep;53 Suppl 2:S310-29
pubmed: 19437486
Gastroenterol Res Pract. 2018 Nov 26;2018:2097359
pubmed: 30598661
J Clin Epidemiol. 1998 Nov;51(11):1025-36
pubmed: 9817120
Eur J Clin Invest. 2020 Mar;50(3):e13201
pubmed: 31960952
BMJ. 1992 Jul 18;305(6846):160-4
pubmed: 1285753
Gastroenterology. 2002 May;122(5):1500-11
pubmed: 11984534
Am J Gastroenterol. 2010 May;105(5):1181-8
pubmed: 19997094
Dig Liver Dis. 2019 Jun;51(6):782-789
pubmed: 30448159
BMC Ophthalmol. 2007 Mar 29;7:5
pubmed: 17394642
Health Econ. 1993 Oct;2(3):217-27
pubmed: 8275167
BMC Gastroenterol. 2015 Oct 30;15:153
pubmed: 26518158
Therap Adv Gastroenterol. 2017 Feb;10(2):253-275
pubmed: 28203283
Curr Med Res Opin. 2018 Mar;34(3):377-385
pubmed: 28604115
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Scand J Gastroenterol. 1997 Sep;32(9):920-4
pubmed: 9299672
Int J Mol Sci. 2018 Feb 27;19(3):
pubmed: 29495535
United European Gastroenterol J. 2019 Oct;7(8):1093-1101
pubmed: 31662866
World J Gastroenterol. 2003 Oct;9(10):2293-9
pubmed: 14562396
JPEN J Parenter Enteral Nutr. 2016 Nov;40(8):1170-1176
pubmed: 25972430
Clin Chim Acta. 2013 Mar 15;418:97-101
pubmed: 23328210
Aliment Pharmacol Ther. 1997 Apr;11(2):395-402
pubmed: 9146781
Gut. 2008 Jan;57(1):7-9
pubmed: 18094198
Int J Sport Nutr Exerc Metab. 2019 Feb 22;29(4):411–419
pubmed: 30632417
Gastroenterology. 2016 Feb 18;:
pubmed: 27144627
World J Gastroenterol. 2014 Jul 21;20(27):8807-20
pubmed: 25083055

Auteurs

Massimo Bellini (M)

Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Ginevra Berti (G)

Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Leonilde Bonfrate (L)

Clinica Medica A. Murri, Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro Medical School, Bari, Italy.

Flavia Ciranni (F)

Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Agostino Di Ciaula (A)

Clinica Medica A. Murri, Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro Medical School, Bari, Italy.

Mirko Di Ruscio (M)

IBD Unit, IRCCS Ospedale Sacro Cuore-Don Calabria, Negrar di Valpolicella, Verona, Italy.

Alessandra Dell'Era (A)

Department of Biomedical and Clinical Sciences, "Luigi Sacco", University of Milan, Milan, Italy.
Gastroenterology and Endoscopy Unit - ASST Fatebenefratelli Sacco, Milan, Italy.

Christian Lambiase (C)

Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Antonino Noto (A)

Clinica Medica A. Murri, Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro Medical School, Bari, Italy.

Andrea Pancetti (A)

Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Piero Portincasa (P)

Clinica Medica A. Murri, Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro Medical School, Bari, Italy.

Francesco Rettura (F)

Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Classifications MeSH